These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 227968)
1. The influence of defective-interfering particles of the PR-8 strain of influenza A virus on the pathogenesis of pulmonary infection in mice. Rabinowitz SG; Huprikar J J Infect Dis; 1979 Sep; 140(3):305-15. PubMed ID: 227968 [TBL] [Abstract][Full Text] [Related]
2. [Properties of influenza virus isolated from the bodies of mice at different stages of experimental influenza]. Frolov AF; Shcherbinskaia AM; Sklianskaia EI Vopr Virusol; 1981; (5):544-7. PubMed ID: 7336682 [TBL] [Abstract][Full Text] [Related]
3. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung. Duhaut SD; Dimmock NJ Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233 [TBL] [Abstract][Full Text] [Related]
4. Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication. Dimmock NJ; Beck S; McLain L J Gen Virol; 1986 May; 67 ( Pt 5)():839-50. PubMed ID: 2422317 [TBL] [Abstract][Full Text] [Related]
5. Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus. Noble S; Dimmock NJ J Gen Virol; 1994 Dec; 75 ( Pt 12)():3485-91. PubMed ID: 7996140 [TBL] [Abstract][Full Text] [Related]
6. Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production. Frensing T; Pflugmacher A; Bachmann M; Peschel B; Reichl U Appl Microbiol Biotechnol; 2014 Nov; 98(21):8999-9008. PubMed ID: 25132064 [TBL] [Abstract][Full Text] [Related]
7. The influence of endogenous hypocorticism on the replication of influenza virus in the mouse lungs and the production of specific antibodies. Semenkov VF; Levina LV; Lavrov VF; Ageeva ON Acta Virol; 1990 Feb; 34(1):37-43. PubMed ID: 1975723 [TBL] [Abstract][Full Text] [Related]
8. Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo. Scott PD; Meng B; Marriott AC; Easton AJ; Dimmock NJ Vaccine; 2011 Sep; 29(38):6584-91. PubMed ID: 21762748 [TBL] [Abstract][Full Text] [Related]
9. Protection of three strains of mice against lethal influenza in vivo by defective interfering virus. Morgan DJ; McLain L; Dimmock NJ Virus Res; 1993 Aug; 29(2):179-83. PubMed ID: 8212859 [TBL] [Abstract][Full Text] [Related]
10. Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus. McLain L; Dimmock NJ J Gen Virol; 1989 Oct; 70 ( Pt 10)():2615-24. PubMed ID: 2794973 [TBL] [Abstract][Full Text] [Related]
11. Protection of mice from lethal influenza by defective interfering virus: T cell responses. McLain L; Morgan DJ; Dimmock NJ J Gen Virol; 1992 Feb; 73 ( Pt 2)():375-81. PubMed ID: 1371542 [TBL] [Abstract][Full Text] [Related]
12. Dynamics of viral growth, viral enzymatic activity, and antigenicity in murine lungs during the course of influenza pneumonia. Astry CL; Yolken RH; Jakab GJ J Med Virol; 1984; 14(2):81-90. PubMed ID: 6491644 [TBL] [Abstract][Full Text] [Related]
13. A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection. Pieler MM; Frentzel S; Bruder D; Wolff MW; Reichl U Vaccine; 2016 Dec; 34(50):6367-6374. PubMed ID: 27816372 [TBL] [Abstract][Full Text] [Related]
14. Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation and Reduces the Inflammatory Response in Mice. Wang C; Honce R; Salvatore M; Chow D; Randazzo D; Yang J; Twells NM; Mahal LK; Schultz-Cherry S; Ghedin E J Virol; 2023 Jun; 97(6):e0049323. PubMed ID: 37255439 [TBL] [Abstract][Full Text] [Related]
15. Generation of a purely clonal defective interfering influenza virus. Yamagata Y; Muramoto Y; Miyamoto S; Shindo K; Nakano M; Noda T Microbiol Immunol; 2019 May; 63(5):164-171. PubMed ID: 30997933 [TBL] [Abstract][Full Text] [Related]
16. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. Noble S; McLain L; Dimmock NJ Vaccine; 2004 Aug; 22(23-24):3018-25. PubMed ID: 15297051 [TBL] [Abstract][Full Text] [Related]
17. One defective interfering particle per cell prevents influenza virus-mediated cytopathology: an efficient assay system. McLain L; Armstrong SJ; Dimmock NJ J Gen Virol; 1988 Jun; 69 ( Pt 6)():1415-9. PubMed ID: 3385408 [TBL] [Abstract][Full Text] [Related]
18. Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse. Morgan DJ; Dimmock NJ J Virol; 1992 Feb; 66(2):1188-92. PubMed ID: 1731097 [TBL] [Abstract][Full Text] [Related]
19. Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAs. Noble S; Dimmock NJ Virology; 1995 Jun; 210(1):9-19. PubMed ID: 7793084 [TBL] [Abstract][Full Text] [Related]
20. [Studies of the adaptation of influenza viruses to lowered temperatures of replication. II. Studies in vivo]. Brydak L; Sadowski W Med Dosw Mikrobiol; 1990; 42(1-2):50-3. PubMed ID: 1964991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]